Browse by author
Lookup NU author(s): Dr Tim Blackburn
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The development of a series of GABAA α2/α3 subtype selective pyridazine based benzodiazepine site agonists as anxiolytic agents with reduced sedative/ataxic potential is described, including the discovery of 16, a remarkably α3-selective compound ideal for in vivo study. These ligands are antagonists at the α1 subtype, with good CNS penetration and receptor occupancy, and excellent oral bioavailability.
Author(s): Lewis R, Blackaby W, Blackburn T, Jennings A, Pike A, Wilson R, Hallet D, Cook S, Pushpinder F, Marshall G, Reynolds D, Sheppard W, Smith A, Sohal B, Stanley J, Tye S, Wafford K, Atack J
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Year: 2006
Volume: 49
Issue: 8
Pages: 2600-2610
Print publication date: 22/03/2006
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
Publisher: ACS Publications
URL: https://doi.org/10.1021/jm051144x
DOI: 10.1021/jm051144x
Altmetrics provided by Altmetric